L. Lipsitz et al., Persistent fetal intraocular vasculature in the European ferret (Mustela putorius): clinical and histological aspects, VET OPHTHAL, 4(1), 2001, pp. 29-33
Objective To describe the clinical and histological appearance of persisten
t fetal intraocular vasculature in a colony of ferrets.
Design Prospective study.
Animals studied Eighty-six European ferrets (Mustela putorius).
Procedure Both eyes of 76 genetically related progeny and 10 breeding, adul
t, colony-raised ferrets were studied using a slit lamp biomicroscope and a
n indirect ophthalmoscope. Ferret progeny were examined after eyelid openin
g at 5-6 weeks of age, and at 12 months of age. After euthanasia, globes we
re enucleated and examined histologically.
Results Persistent fetal intraocular vasculature was evident in 21 progeny
ferrets at 5-6 weeks of age and in three mature progenitor ferrets. Clinica
l appearance of diminutive vasculature was characterized by focal remnants
of the posterior tunica vasculosa lentis, muscae volitantes, and an occlude
d hyaloid artery extending from the optic papilla and terminating in the an
terior vitreous body. Extensive persistent vasculature was characterized by
a perfused hyaloid artery, vasa hyaloidea propria and posterior tunica vas
culosa lentis, posterior cortical and capsular cataract, and proliferation
of fibrovascular tissue along the posterior tens capsule. Fetal vasculature
persisted in 7 of 21 progeny ferrets at one year of age and in three proge
nitor ferrets. Results of histologic examination showed persistence of the
hyaloid vasculature, proliferation of retrolental fibrovascular tissue with
osseous metaplasia, posterior capsular and cortical cataract, and occasion
al retinal detachment.
Conclusions Persistent fetal intraocular vasculature in ferrets appears sim
ilar clinically and histologically to persistent fetal intraocular vasculat
ure reported in humans and dogs. The ferret may be a suitable animal model
for vasculogenic mechanisms of persistent fetal intraocular vasculature and
for evaluating vasoinhibitory growth factors and angiostatic test compound
s.